121 related articles for article (PubMed ID: 38453033)
1. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
Mehan S; Monga V; Rani M; Dudi R; Ghimire K
Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
[TBL] [Abstract][Full Text] [Related]
4. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
5. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
Wells RG; Azzam AF; Hiller AL; Sardinia MF
J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
[TBL] [Abstract][Full Text] [Related]
6. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
Hariharan A; Shetty S; Shirole T; Jagtap AG
Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
[TBL] [Abstract][Full Text] [Related]
7. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.
Kumar P; Padi SS; Naidu PS; Kumar A
Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769
[TBL] [Abstract][Full Text] [Related]
8. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
Kumar P; Kalonia H; Kumar A
Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
10. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya SN; Sumathi T
Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
[TBL] [Abstract][Full Text] [Related]
11. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
12. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters.
Jamwal S; Kumar P
Physiol Behav; 2016 Mar; 155():180-7. PubMed ID: 26703234
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
Mehrotra A; Sood A; Sandhir R
Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
Binawade Y; Jagtap A
J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
[TBL] [Abstract][Full Text] [Related]
15. Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain.
Kumar P; Kalonia H; Kumar A
Drug Chem Toxicol; 2010 Oct; 33(4):377-92. PubMed ID: 20550427
[TBL] [Abstract][Full Text] [Related]
16. Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease.
Moghaddam MH; Bayat AH; Eskandari N; Abdollahifar MA; Fotouhi F; Forouzannia A; Rafiei R; Hatari S; Seraj A; Shahidi AMEJ; Ghorbani Z; Peyvandi AA; Aliaghaei A
Brain Res; 2021 Jul; 1762():147444. PubMed ID: 33745925
[TBL] [Abstract][Full Text] [Related]
17. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease.
Chakraborty J; Nthenge-Ngumbau DN; Rajamma U; Mohanakumar KP
Behav Brain Res; 2014 May; 264():91-104. PubMed ID: 24509309
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
Sidhu A; Diwan V; Kaur H; Bhateja D; Singh CK; Sharma S; Padi SSV
Metab Brain Dis; 2018 Dec; 33(6):1911-1921. PubMed ID: 30054774
[TBL] [Abstract][Full Text] [Related]
20. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.
Malik J; Karan M; Dogra R
Pharm Biol; 2017 Dec; 55(1):980-990. PubMed ID: 28164735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
